Legal & General Group PLC Bellus Health Inc. Transaction History

Legal & General Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.22 - $10.76 $7,299 - $9,554	888 Added 6.87%	13,819 $113,000
Q3 2022 Nov 14, 2022	BUY	$8.95 - $12.0 $42,807 - $57,396	4,783 Added 58.7%	12,931 $131,000
Q2 2022 Aug 22, 2022	BUY	$6.46 - $10.02 $52,636 - $81,642	8,148 New	8,148 $75,000
Q4 2020 Feb 12, 2021	SELL	$2.27 - $3.3 $2,081 - $3,026	-917 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$8.88 - $11.15 $8,142 - $10,224	917 New	917 $9,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.